AKTIV-DRY LLC, a spin-out company formed from University of Colorado, provides dry powder stabilization and processing solutions for the vaccine, pharmaceutical, and biotechnology industries. The company is particularly interested in particle stabilization, synthesis, drying and coating technologies. AKTIV-DRY has a proven track record in micronizing and gently drying vaccines, antibodies, enzymes, proteins and other pharmaceutical compounds. AKTIV-DRY engineers particle sizes and morphology to satisfy your requirements. Licenses are available for the patents and intellectual property shown on the page with that name. The firm is trying to develop a measles vaccine that can be stored dry and inhaled which turns it into glassy particles surrounding a matrix of trehalose, the sugar that allows brine shrimp cysts to survive dried out for years but hatch into wriggling creatures in seawater.